The Efficacy of Vitamin D Supplementation in Patients With Severe and Extremely Severe COVID-19

NACompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

May 1, 2020

Primary Completion Date

December 31, 2021

Study Completion Date

January 31, 2022

Conditions
SARS-CoV2 Infection
Interventions
DIETARY_SUPPLEMENT

Vitamin D (cholecalciferol)

Patients will receive 60,000 IU of cholecalciferol dissolved in 45 ml herbal oil orally or via feeding tube after serum Vitamin D concentrations measurement followed by the same dose of cholecalciferol weekly and 5,000 IU of cholecalciferol (two drops) daily until discharge or death.

DIETARY_SUPPLEMENT

Herbal oil

Patients will receive 45 ml of herbal oil orally or via feeding tube after serum Vitamin D concentrations measurement followed by the same dose of pure herbal oil weekly and two drops of herbal oil daily until discharge or death.

Trial Locations (1)

115682

Federal Research Clinical Center of Federal Medical & Biological Agency, Moscow

All Listed Sponsors
lead

Federal Research Clinical Center of Federal Medical & Biological Agency, Russia

OTHER_GOV

NCT05092698 - The Efficacy of Vitamin D Supplementation in Patients With Severe and Extremely Severe COVID-19 | Biotech Hunter | Biotech Hunter